Study List:

Study 1:
  Title:                    Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Intrahepatic Cholangiocarcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01862276

Study 2:
  Title:                    Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Intrahepatic Cholangiocarcinoma
  Interventions:            Radiation: Stereotactic radiation
  URL:                      https://ClinicalTrials.gov/show/NCT01668134

Study 3:
  Title:                    Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Intrahepatic Cholangiocarcinoma|Mixed Hepatocellular Cholangiocarcinoma|Cholangiocarcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02762721

Study 4:
  Title:                    Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Bile Duct Cancer|Intrahepatic Cholangiocarcinoma|Cholangiocarcinoma of the Extrahepatic Bile Duct
  Interventions:            Drug: Cabozantinib
  URL:                      https://ClinicalTrials.gov/show/NCT01954745

Study 5:
  Title:                    Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Biliary Tract Cancer|Gallbladder Cancer|Cancer Of The Extrahepatic Bile Duct|Ampullary Carcinoma
  Interventions:            Drug: ZD6474, Vandetanib|Drug: ZD6474, Vandetanib|Drug: Gemcitabine|Drug: Placebo matching ZD6474
  URL:                      https://ClinicalTrials.gov/show/NCT00753675

Study 6:
  Title:                    Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Solid Tumor|Glioma|Angioimmunoblastic T-cell Lymphoma|Intrahepatic Cholangiocarcinoma|Chondrosarcoma
  Interventions:            Drug: AG-221
  URL:                      https://ClinicalTrials.gov/show/NCT02273739

Study 7:
  Title:                    Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Cholangiocarcinoma
  Interventions:            Device: TheraSphereÂ® Yttrium-90 (Y-90) Microspheres
  URL:                      https://ClinicalTrials.gov/show/NCT01253148

Study 8:
  Title:                    Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cholangiocellular Carcinoma
  Interventions:            Drug: Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin
  URL:                      https://ClinicalTrials.gov/show/NCT01692704

Study 9:
  Title:                    Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver and Intrahepatic Biliary Tract Cancer|Recurrent Extrahepatic Bile Duct Cancer|Unresectable Extrahepatic Bile Duct Cancer
  Interventions:            Drug: selumetinib|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00553332

